FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Ophthalmic device has an eye fluid analysis system and comprises a multi-element annular carrier insert comprising a front insertion member and a rear insert member, connected and together sealed; energy source sealed inside the carrier insert; microfluidic analytical system sealed within a carrier insert and in electrical connection with an energy source, wherein microfluidic analytical system is operable to measure one or more properties of a sample of the ocular fluid; processor forming part of said carrier insert and configured to perform a program including pre-programmed threshold values for one or more properties of the eye fluid, and output of the signal when the measurement results are outside the limits of the corresponding pre-programmed threshold values; and an artificial pore that connects the microfluidic analytic system with the eye fluid external to the ophthalmic device. Method for monitoring glucose levels comprises the steps of: programming an ophthalmological device with threshold values for a normal concentration of glucose biomarkers; place the ophthalmic device in contact with the anterior surface of the eye; receive a sample of the eye fluid with the help of the microfluidic element of the ophthalmic device; measuring one or more properties of the eye fluid by means of one or more components of an ophthalmic device sensor; algorithm is used to compensate for the time delay when the measured properties change with respect to the condition that caused the abnormal glucose level; processing the results of measuring one or more properties of the eye fluid to determine if the concentration of glucose biomarkers is within the programmed threshold values; identify the condition that caused the change in glucose levels.
EFFECT: application of this group of inventions will allow the control of a small volume of fluid.
20 cl, 13 dwg
